Inspire HGNS denied for failing step therapy by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for inspire hgns are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied the Inspire HGNS System Under Step Therapy — and Why You Can Appeal

Blue Cross Blue Shield step-therapy protocols require patients to try and fail less invasive or less costly treatments before a higher-tier intervention is authorized. For obstructive sleep apnea (OSA) and the Inspire Hypoglossal Nerve Stimulation system, this typically means demonstrating an adequate, documented trial of positive airway pressure (PAP) therapy — such as CPAP or BiPAP — that was either clinically insufficient or could not be tolerated. If your records did not clearly document that prior step, BCBS may deny the device as premature.

This denial is commonly overturned on appeal when the record is complete, because the FDA-approved indication for the Inspire device itself requires documented PAP inadequacy or intolerance — so meeting the device's own criteria often simultaneously satisfies the insurer's step-therapy requirement.

## Federal Appeal Rights

ACA §2719 guarantees at least two internal appeals and external review for most non-grandfathered plans. ERISA §503 requires full-and-fair review in employer plans. You generally have 180 days from the denial notice to request external review (confirm on your Explanation of Benefits). Expedited review is available within approximately 72 hours when delay would jeopardize your health or ability to regain maximum function.

## Concrete Appeal Process

1. Obtain the denial letter and BCBS's medical policy for hypoglossal nerve stimulation, noting every step-therapy requirement listed. 2. File a Level 1 internal appeal. Attach all PAP-therapy records: the original prescription, device download data (AHI, hours of use, leak data), clinic follow-up notes, and a physician statement explaining why PAP was inadequate or could not be tolerated. 3. If upheld, file a Level 2 internal appeal with any additional specialist documentation. 4. Escalate to independent external review if internal appeals are exhausted.

## Documentation to Gather

• Diagnosis confirmation: Polysomnography report with severity classification, interpreted by a sleep medicine specialist.
• PAP trial history: Dates therapy was initiated and discontinued, objective adherence downloads, and clinic notes documenting follow-up efforts and outcomes.
• Failure/intolerance documentation: Physician narrative explaining the clinical reason PAP was inadequate — anatomical, physiological, or tolerance-based — tied to specific chart entries with dates.
• Clinical severity: Notes on cardiovascular, neurocognitive, or functional consequences of ongoing untreated OSA.
• Prescriber medical-necessity letter: A statement from the implanting surgeon or sleep medicine physician mapping the patient's history directly to each criterion in BCBS's step-therapy policy.

## Criteria-Mapping Structure

List each step-therapy requirement from BCBS's published policy in a table. In the adjacent column, cite the exact document, date, and finding from the medical record that satisfies it. A clear, side-by-side mapping — rather than a narrative summary — is the most persuasive format for a step-therapy appeal and gives the reviewer no ambiguity about whether each gate was cleared.